Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1337206
                    [Title] => FDA bans medicine for blood clot
                    [Summary] => 
The Food and Drugs Administration (FDA) has temporarily banned the sale of a medicine used to treat blood clot from India due to reported serious adverse reactions to the drug.

                    [DatePublished] => 2014-06-21 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1097338
                    [AuthorName] =>  Mayen Jaymalin
                    [SectionName] => Metro
                    [SectionUrl] => metro
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 155682
                    [Title] => Clot-dissolving therapy improves heart patients
                    [Summary] => ATLANTA, Georgia – Administering the clot-dissolving drug alteplase (Actilyse, Boehringer Ingelheim) early during massive pulmonary embolism prevents the disease from worsening, a new clinical trial showed. 


Patients who benefited from the treatment had signs of right-heart strain at presentation. Their hearts were laboring to function despite the presence of clots obstructing the pulmonary arteries, but the patients appeared hemodynamically stable or they had normal blood pressure. 


                    [DatePublished] => 2002-04-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

HEPARIN

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1337206
                    [Title] => FDA bans medicine for blood clot
                    [Summary] => 
The Food and Drugs Administration (FDA) has temporarily banned the sale of a medicine used to treat blood clot from India due to reported serious adverse reactions to the drug.

                    [DatePublished] => 2014-06-21 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1097338
                    [AuthorName] =>  Mayen Jaymalin
                    [SectionName] => Metro
                    [SectionUrl] => metro
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 155682
                    [Title] => Clot-dissolving therapy improves heart patients
                    [Summary] => ATLANTA, Georgia – Administering the clot-dissolving drug alteplase (Actilyse, Boehringer Ingelheim) early during massive pulmonary embolism prevents the disease from worsening, a new clinical trial showed. 


Patients who benefited from the treatment had signs of right-heart strain at presentation. Their hearts were laboring to function despite the presence of clots obstructing the pulmonary arteries, but the patients appeared hemodynamically stable or they had normal blood pressure. 


                    [DatePublished] => 2002-04-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

FDA bans medicine for blood clot

By Mayen Jaymalin | June 21, 2014 - 12:00am

The Food and Drugs Administration (FDA) has temporarily banned the sale of a medicine used to treat blood clot from India due to reported serious adverse reactions to the drug.

Metro

Clot-dissolving therapy improves heart patients

April 1, 2002 - 12:00am

ATLANTA, Georgia – Administering the clot-dissolving drug alteplase (Actilyse, Boehringer Ingelheim) early during massive pulmonary embolism prevents the disease from worsening, a new clinical trial showed....

Science and Environment